PS Biotech GmbH, an Aachen, Germany-based startup dedicated to facilitating the selection of optimal bacterial strain for recombinant protein production processes, received seed funding from High-Tech Startup Fund (High-Tech Gründerfonds).
Established in May 2013 as a spin-off of the RWTH Aachen and DWI at the RWTH Aachen, PS Biotech has developed a process for the production of microtiter plates, which allows a realistic screening under fed-batch conditions.
The company, which is led by Kristina Bruellhoff and Sebastian Selzer, will deliver its products to its customers from autumn 2013.
FinSMEs
02/09/2013